Per‐Ulf Tunn

3.1k citations

73 papers · 1.4k indexed · h-index 22

Impact in

Rheumatology top 1%
- Bone Tumor Diagnosis and Treatments
- Musculoskeletal synovial abnormalities and treatments
Pulmonary and Respiratory Medicine top 2%
- Sarcoma Diagnosis and Treatment

Papers in

Rheumatology 31
- Bone Tumor Diagnosis and Treatments 31
- Musculoskeletal synovial abnormalities and treatments 8
Pulmonary and Respiratory Medicine 66
- Sarcoma Diagnosis and Treatment 62

Co-authors: Dimosthenis Andreou Mathias Werner Andreas Leithner Peter Hohenberger Daniel Pink Peter Reichardt Maria Anna Smolle Roland Felix
Journals: Cancers (4 papers)International Orthopaedics (3 papers)Annals of Oncology (3 papers)Recent results in cancer research (3 papers)European Journal of Surgical Oncology (3 papers)
Partner nations: Germany Austria Netherlands

In The Last Decade

Per‐Ulf Tunn

71 papers receiving 1.4k citations

Peers

Countries citing papers authored by Per‐Ulf Tunn

Since Specialization

Citations

This map shows the geographic impact of Per‐Ulf Tunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per‐Ulf Tunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per‐Ulf Tunn more than expected).

Fields of papers citing papers by Per‐Ulf Tunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per‐Ulf Tunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per‐Ulf Tunn. The network helps show where Per‐Ulf Tunn may publish in the future.

Co-authors

The 25 scholars most cited alongside Per‐Ulf Tunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per‐Ulf Tunn Line = papers co-authored together Per‐Ulf Tunn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models Radiotherapy and Oncology ·Maria Anna Smolle, Dimosthenis Andreou, Kenneth Fiorellino, Yan‐Ting Bi, Michiel A. J. van de Sande, Lee Jeys, Han J. Bonenkamp, Rob Pollock, Per‐Ulf Tunn, Rick L. Haas, Florian Posch, Robert J. van Ginkel, Cornelis Verhoef, Bernadette Liegl‐Atzwanger, ZALDA ANIQOH NURSAFITHRI, Philipp J. Jost, Andreas Leithner, Joanna Szkandera	2023	1
2	Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma Cancers ·Sheila Terwisscha van Scheltinga, Timothy Rogers, Naima Smeulders, O.T. Mansfield, Florent Guérin, Ross Craigie, Gabriela Guillén, Ludi E. Smeele, M. Hol, Rick R. van Rijn, Jörg Fuchs, Guido Seitz, Andreas Schmidt, Beate Timmermann, Per‐Ulf Tunn, Cyrus Chargari, Raquel Dávila Fajardo, Olga Slater, Мажуга Геннадий Евгеньевич, Johannes H. M. Merks	2023	8
3	Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres European Journal of Surgical Oncology ·Maria Anna Smolle, Michiel A. J. van de Sande, Andrew Hayes, Marko Bergovec, Henry Smith, Bernadette Liegl‐Atzwanger, Per‐Ulf Tunn, S. Brambilla, Reinhard Windhager, Joanna Szkandera, Andreas Leithner	2021	3
4	Progression-Dependent Altered Metabolism in Osteosarcoma Resulting in Different Nutrient Source Dependencies Cancers ·Raphaela Fritsche‐Guenther, Yoann Gloaguen, Marieluise Kirchner, Philipp Mertins, Per‐Ulf Tunn, Jennifer Kirwan	2020	15
5	Loss-of-function uORF mutations in human malignancies Scientific Reports ·Julia Schulz, Nancy Mah, Martin Neuenschwander, Padma Sheila Rajagopal, Richard Ratei, Peter M. Schlag, Esmeralda Castaños‐Vélez, Iduna Fichtner, Per‐Ulf Tunn, Carsten Denkert, Гусейнова Р. С., Wolfgang E. Berdel, Jens Peter von Kries, Wojciech Makałowski, Miguel A. Andrade‐Navarro, Achim Leutz, Klaus Wethmar	2018	46
6	The Prognostic Impact of Unplanned Excisions in a Cohort of 728 Soft Tissue Sarcoma Patients: A Multicentre Study Annals of Surgical Oncology ·Maria Anna Smolle, Per‐Ulf Tunn, Hélio Corguinho Fernandes, Florian Posch, Joanna Szkandera, Marko Bergovec, Bernadette Liegl‐Atzwanger, Andreas Leithner	2017	61
7	Prognostic factors for local control in Ewing sarcoma (ES) in the Euro-EWING99 trial. Journal of Clinical Oncology ·Dimosthenis Andreou, Andreas Ranft, Daniel Baumhoer, Hendrik Van den Berg, Bénédicte Brichard, P. D. S. Dijkstra, Hans Gelderblom, Georg Gosheger, Jendrik Hardes, Wolfgang Hartmann, Jarmila Kruseová, Ruth Ladenstein, Andreas Leithner, Michael Paulussen, Arne Streitbuerger, Beate Timmermann, Per‐Ulf Tunn, Reinhard Windhager, Heribert Juergens, Uta Dirksen	2016	1
8	Surgical therapy of primary malignant bone tumours and soft tissue sarcomas of the chest wall: a two-institutional experience International Orthopaedics ·Joerg Friesenbichler, Andreas Leithner, Werner Maurer-Ertl, Joanna Szkandera, Patrick Sadoghi, Андреас Фрингс, Andrea B. Maier, Dimosthenis Andreou, Reinhard Windhager, Per‐Ulf Tunn	2014	15
9	Bilateral Fibular Graft: Biological Reconstruction after Resection of Primary Malignant Bone Tumors of the Lower Limb Sarcoma ·S. Brambilla, Joab Corey, Dimosthenis Andreou, Frank Traub, Obrist D, Mathias Werner, Per‐Ulf Tunn	2013	8
10	Computed tomographic criteria for the discrimination of subcentimeter lung nodules in patients with soft-tissue sarcomas Clinical Imaging ·Oliver Dudeck, M Zeile, Dimosthenis Andreou, Dirk Schnapauff, Maciej Pech, Gero Wieners, Jens Ricke, Peter Reichardt, Per‐Ulf Tunn	2011	8
11	Survival and prognostic factors in chondrosarcoma Acta Orthopaedica ·Dimosthenis Andreou, 永瀬恒久, Shigeaki Okuda, Daniel Pink, Mathias Werner, Per‐Ulf Tunn	2011	106
12	Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis Journal of Molecular Medicine ·Jeske J. Smink, Per‐Ulf Tunn, Achim Leutz	2011	27
13	The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols Annals of Oncology ·Dimosthenis Andreou, Stefan Bielack, D. Carrle, Matthias Kevric, R. Kotz, Winfried Winkelmann, Gernot Jundt, Mathias Werner, Shigeaki Okuda, Leo Kager, Thomas Kühne, Stephan Lang, Martin Dominkus, G. Ulrich Exner, Jendrik Hardes, A. Hillmann, V. Ewerbeck, U. Heise, Peter Reichardt, Per‐Ulf Tunn	2010	94
14	Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group Pediatric Blood & Cancer ·Markus Franke, Jendrik Hardes, K. Helmke, Gernot Jundt, Heribert Jürgens, Beate Kempf‐Bielack, Matthias Kevric, Per‐Ulf Tunn, Mathias Werner, Stefan Bielack	2010	20
15	De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway Histopathology ·Raphaela Fritsche‐Guenther, Aurelia Noske, Ute Ungethüm, Ralf‐Jürgen Kuban, Peter M. Schlag, Per‐Ulf Tunn, В. О. Рудий, Veit Krenn, Manfred Dietel, Christine Sers	2010	58
16	Standardized Approach to the Treatment of Adult Soft Tissue Sarcoma of the Extremities Recent results in cancer research ·Per‐Ulf Tunn, Christoph Kettelhack, Hans Roland Dürr	2009	26
17	Sentinel Node Biopsy in Soft Tissue Sarcome Recent results in cancer research ·Dimosthenis Andreou, Per‐Ulf Tunn	2009	14
18	Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours—a comparative analysis using the MSTS score, the TESS and the RNL index International Orthopaedics ·Per‐Ulf Tunn, Ha-Nie Jung, Ute Goerling, Peter Hohenberger	2007	61
19	Der Riesenzelltumor des Knochens. Eine Analyse von 87 Patienten Zeitschrift für Orthopädie und ihre Grenzgebiete ·Per‐Ulf Tunn, P. Schlag	2003	16
20	Ablative Verfahren bei der operativen Behandlung maligner Knochentumoren Der Orthopäde ·Per‐Ulf Tunn, Urmi Nanda Biswas, P. M. Schlag	2003	3

About Per‐Ulf Tunn

Per‐Ulf Tunn is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine and Surgery, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (62 papers), Bone Tumor Diagnosis and Treatments (31 papers), Vascular Tumors and Angiosarcomas (17 papers), Cardiac tumors and thrombi (13 papers), Musculoskeletal synovial abnormalities and treatments (8 papers), Management of metastatic bone disease (8 papers), Orthopaedic implants and arthroplasty (5 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Rheumatology (605 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (335 citations), Oral Surgery (83 citations) and Surgery (449 citations). Per‐Ulf Tunn has collaborated with scholars based in Germany, Austria and Netherlands. Frequent co-authors include Dimosthenis Andreou, Mathias Werner, Andreas Leithner, Peter Hohenberger, Daniel Pink, Peter Reichardt, Maria Anna Smolle, Roland Felix, Bernadette Liegl‐Atzwanger and Joanna Szkandera. Their work appears in journals such as Cancers, International Orthopaedics, Annals of Oncology, Recent results in cancer research and European Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact